SURGEPAYS INC (SURG)
US86882L2043 - Common Stock
We assign a fundamental rating of 4 out of 10 to SURG. SURG was compared to 22 industry peers in the Wireless Telecommunication Services industry. While SURG has a great health rating, there are worries on its profitability. SURG is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
SURG had negative earnings in the past year.
In the past year SURG had a positive cash flow from operations.
SURG had negative earnings in 4 of the past 5 years.
In multiple years SURG reported negative operating cash flow during the last 5 years.
1.2 Ratios
SURG has a Return On Assets of -2.72%. This is in the lower half of the industry: SURG underperforms 76.19% of its industry peers.
SURG has a worse Return On Equity (-3.33%) than 76.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.72% | ||
| ROE | -3.33% | ||
| ROIC | N/A |
ROA(3y)-7.37%
ROA(5y)-50.43%
ROE(3y)-107.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SURG has a Gross Margin of 20.06%. This is amonst the worse of the industry: SURG underperforms 85.71% of its industry peers.
SURG's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for SURG so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.06% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y78.16%
GM growth 5Y-10.03%
2. Health
2.1 Basic Checks
SURG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SURG has been increased compared to 1 year ago.
SURG has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SURG has an improved debt to assets ratio.
2.2 Solvency
SURG has an Altman-Z score of 3.89. This indicates that SURG is financially healthy and has little risk of bankruptcy at the moment.
SURG's Altman-Z score of 3.89 is amongst the best of the industry. SURG outperforms 95.24% of its industry peers.
The Debt to FCF ratio of SURG is 0.48, which is an excellent value as it means it would take SURG, only 0.48 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.48, SURG belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
SURG has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
SURG has a better Debt to Equity ratio (0.10) than 90.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.48 | ||
| Altman-Z | 3.89 |
ROIC/WACCN/A
WACC7.9%
2.3 Liquidity
A Current Ratio of 7.38 indicates that SURG has no problem at all paying its short term obligations.
With an excellent Current ratio value of 7.38, SURG belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 6.11 indicates that SURG has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 6.11, SURG belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.38 | ||
| Quick Ratio | 6.11 |
3. Growth
3.1 Past
The earnings per share for SURG have decreased strongly by -177.93% in the last year.
SURG shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.87%.
Measured over the past years, SURG shows a very strong growth in Revenue. The Revenue has been growing by 55.26% on average per year.
EPS 1Y (TTM)-177.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-248.98%
Revenue 1Y (TTM)12.87%
Revenue growth 3Y36.1%
Revenue growth 5Y55.26%
Sales Q2Q%-86.04%
3.2 Future
The Earnings Per Share is expected to decrease by -43.74% on average over the next years. This is quite bad
The Revenue is expected to decrease by -34.80% on average over the next years. This is quite bad
EPS Next Y-181.21%
EPS Next 2Y-43.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-56.88%
Revenue Next 2Y-34.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SURG. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SURG. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
95.24% of the companies in the same industry are more expensive than SURG, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.95 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
SURG's earnings are expected to decrease with -43.74% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-43.74%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for SURG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SURGEPAYS INC
NASDAQ:SURG (11/20/2024, 8:00:00 PM)
Premarket: 1.47 +0.01 (+0.68%)1.46
-0.1 (-6.41%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap29.43M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.72% | ||
| ROE | -3.33% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.06% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 7.38 | ||
| Quick Ratio | 6.11 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-177.93%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-181.21%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.87%
Revenue growth 3Y36.1%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y